Nearly two-thirds of U.S. adults with disabilities surveyed during February and March reported adverse mental health symptoms or substance use early this year, compared with about one-third of adults without disabilities, according to a report released this week by the Centers for Disease Control and Prevention. Serious suicidal ideation was about 2.5 times as high among adults with disabilities. Past-month substance use also was higher among adults with disabilities (40.6%) than without (24.5%).  
 
“These findings suggest value in enhanced mental health screening among adults with disabilities and in ensuring accessibility of routine and crisis services, particularly given that many adults reported that the COVID-19 pandemic had reduced mental health and substance use care or medication accessibility,” the authors said. 
 
In other news, CDC released the first multistate report to examine recent trends in overdoses involving benzodiazepines, which shows emergency department visits for overdoses involving benzodiazepines increased 23.7% from 2019 to 2020. The authors of the study noted that these trends highlight the need to enhance efforts to mitigate harm from simultaneously using benzodiazepines and opioids, including educational efforts to emphasize the dangers of using illicit benzodiazepines. 
 

Related News Articles

Headline
A Gallup report published Sept. 9 found that nearly 48 million Americans currently have or are being treated for depression. The total, which equals 18.3% of…
Headline
The Food and Drug Administration Sept. 10 released draft guidance on non-opioid treatments for treating chronic pain and reducing prescription opioid misuse.…
Headline
A Health Affairs study published Sept. 2 found that less than 40% of Medicare beneficiaries with opioid use disorder received standard care in alignment with…
Blog
In this insightful conversation hosted by Nancy Myers of the American Hospital Association, we explore how Owensboro Health (Ky.) and CredibleMind are…
Headline
The Centers for Disease Control and Prevention Aug. 5 announced a new campaign educating youth ages 12-17 on substance use, mental health and how they are…
Headline
The Food and Drug Administration July 31 announced that it is requiring safety label changes to all opioid pain medications to further emphasize and explain…